ISRG

Intuitive Surgical
D

ISRG

Arincen88/100B

Intuitive Surgical earnings

Intuitive Surgical reports its Q4 FY2026 results on 28 January 2027, after the market closes. Analysts expect earnings per share of 2.96 USD and revenue of 3.24B USD.

In Q3 FY2026, reported on 20 October 2026, Intuitive Surgical earned 3.00 USD a share against the 2.65 USD analysts expected (+13.2%), on revenue of 3.05B USD against 2.91B USD (+4.9%).

Last EPS surprise
+13.2%
Last revenue surprise
+4.9%
Move after the last report
-2.3%
Average move after earnings
7.5%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
2.96 USD
Revenue estimate
3.24B USD
Last quarter · Q3 FY2026
EPS3.00Beat +13.2%Revenue3.05BBeat +4.9%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q3 FY20273.19——+6.44%3.37B——+10.39%—
Q2 FY20273.08——+10.15%3.25B——+12.35%—
Q1 FY20272.86——+1.97%3.12B——+12.74%—
Q4 FY20262.96——+17.00%3.24B——+12.96%—
Q3 FY20262.653.00+13.21%+25.00%2.91B3.05B+4.88%+21.70%-2.3%
Q2 FY20262.512.80+11.55%+27.85%2.83B2.89B+2.37%+18.54%-14.2%
Q1 FY20262.512.80+11.55%+54.70%2.62B2.77B+5.81%+22.96%+7.0%
Q4 FY20252.272.53+11.45%+14.48%2.76B2.87B+3.75%+18.76%-0.4%
Q3 FY20251.992.40+20.60%+30.43%2.41B2.51B+4.10%+22.91%+14.0%
Q2 FY20251.932.19+13.47%+23.03%2.35B2.44B+3.77%+21.40%-2.0%
Q1 FY20251.741.81+4.02%+20.67%2.19B2.25B+3.09%+19.19%+2.0%
Q4 FY20241.762.21+25.57%+38.12%2.25B2.41B+7.32%+25.16%-4.0%
Q3 FY20241.631.84+12.88%+26.03%2.01B2.04B+1.63%+16.88%+10.0%
Q2 FY20241.541.78+15.58%+25.35%1.97B2.01B+1.94%+14.47%+9.4%
Q1 FY20241.411.50+6.38%+21.95%1.87B1.89B+1.09%+11.46%-1.8%
Q4 FY20231.481.60+8.11%+30.08%1.89B1.93B+2.11%+16.51%-0.0%
Q3 FY20231.411.46+3.55%+22.69%1.77B1.74B-1.32%+11.96%-2.3%
Q2 FY20231.331.42+6.77%+24.56%1.74B1.76B+1.07%+15.36%-3.4%
Q1 FY20231.201.23+2.50%+8.85%1.60B1.70B+6.30%+14.01%+10.9%
Q4 FY20221.261.23-2.38%-5.38%1.67B1.66B-0.89%+6.73%-5.5%
Q3 FY20221.101.19+8.18%0.00%1.52B1.56B+2.21%+10.98%+9.1%
Q2 FY20221.161.14-1.72%-12.98%1.56B1.52B-2.46%+3.97%-5.7%
Q1 FY20221.081.13+4.63%-3.42%1.43B1.49B+4.36%+15.14%-14.3%
Q4 FY20211.281.30+1.56%+9.24%1.52B1.55B+1.92%+16.67%-2.8%
Q3 FY20211.171.19+1.71%+29.35%1.39B1.40B+0.79%+30.21%+0.9%
Q2 FY20211.051.31+24.76%+254.05%1.39B1.46B+5.15%+71.81%-1.2%
Q1 FY20210.871.17+34.48%+30.00%1.28B1.29B+0.77%+17.52%+9.9%
Q4 FY20201.041.19+14.42%+2.59%1.13B1.33B+17.33%+4.02%-6.7%
Q3 FY20200.690.92+33.33%-19.30%671.37M1.08B+60.52%-4.48%+1.7%
Q2 FY20200.110.37+236.36%-65.74%643.45M852.10M+32.43%-22.46%+3.5%
Q1 FY20200.850.90+5.88%+3.45%1.04B1.10B+5.91%+12.92%+3.3%
Q4 FY20191.131.16+2.65%+11.54%1.24B1.28B+2.96%+22.09%-4.1%
Q3 FY20191.001.14+14.00%+21.28%983.47M1.13B+14.72%+22.51%+7.0%
Q2 FY20190.961.08+12.50%+17.39%970.41M1.10B+13.24%+20.85%-1.3%
Q1 FY20190.900.87-3.33%+7.41%1.01B973.70M-3.33%+14.89%-7.1%
Q4 FY20181.021.04+1.96%+22.35%1.09B1.05B-3.58%+17.27%-3.9%
Q3 FY20180.890.94+5.62%+2.17%865.58M920.90M+6.39%+14.24%-3.3%
Q2 FY20180.830.92+10.84%+39.39%823.64M909.30M+10.40%+20.25%-0.9%
Q1 FY20180.690.81+17.39%+42.11%718.99M847.50M+17.87%+25.70%+8.1%
Q4 FY20170.760.85+11.84%+25.00%797.18M892.40M+11.94%+17.90%-2.5%
Q3 FY20170.660.92+39.39%+33.33%580.33M806.10M+38.90%+18.04%+3.5%
Q2 FY20170.640.66+3.13%+6.45%739.64M756.20M+2.24%+12.85%-4.6%
Q1 FY20170.550.57+3.64%+16.33%663.61M674.20M+1.60%+13.41%+6.7%
Q4 FY20160.670.68+1.49%+4.62%747.78M756.90M+1.22%+11.88%+5.0%
Q3 FY20160.570.69+21.05%+38.00%570.19M682.90M+19.77%+15.80%-5.6%
Q2 FY20160.550.62+12.73%+21.57%594.85M670.10M+12.65%+14.33%+4.6%
Q1 FY20160.480.49+2.08%+22.50%582.37M594.50M+2.08%+11.73%+3.3%
Q4 FY20150.560.65+16.07%+18.18%579.86M676.50M+16.67%+11.87%+1.9%
Q3 FY20150.470.50+6.38%+13.64%475.13M589.70M+24.11%+7.20%+5.6%
Q2 FY20150.440.51+15.91%+54.55%510.43M586.10M+14.82%+14.43%+8.9%
Q1 FY20150.430.40-6.98%+33.33%576.81M532.10M-7.75%+14.50%-5.4%
Q4 FY20140.490.55+12.24%+14.58%538.33M604.70M+12.33%+4.95%-1.5%
Q3 FY20140.420.44+4.76%0.00%533.26M550.10M+3.16%+10.24%-2.8%
Q2 FY20140.310.33+6.45%-23.26%481.47M512.20M+6.38%-11.46%+17.7%
Q1 FY20140.360.30-16.67%-41.18%569.13M464.70M-18.35%-23.99%-11.5%
Q4 FY20130.430.48+11.63%+2.13%515.76M576.20M+11.72%-5.43%-6.4%
Q3 FY20130.380.44+15.79%+12.82%423.96M499.00M+17.70%-7.21%-5.7%
Q2 FY20130.450.43-4.44%+2.38%600.75M578.50M-3.70%+7.83%-6.8%
Q1 FY20130.440.51+15.91%+30.77%534.98M611.40M+14.29%+23.47%-1.8%
Q4 FY20120.450.47+4.44%+11.90%579.26M609.30M+5.19%+22.64%+9.4%
Q3 FY20120.390.390.00%+14.71%533.24M537.80M+0.85%+20.39%-0.1%
Q2 FY20120.400.42+5.00%+31.25%510.75M536.50M+5.04%+26.03%-8.4%
Q1 FY20120.350.39+11.43%+34.48%444.41M495.20M+11.43%+27.60%+7.2%
Q4 FY20110.370.42+13.51%+23.53%445.13M496.80M+11.61%+27.61%-6.1%
Q3 FY20110.310.34+9.68%+41.67%402.91M446.70M+10.87%+29.70%+9.1%
Q2 FY20110.300.32+6.67%+33.33%394.98M425.70M+7.78%+21.39%+6.0%
Q1 FY20110.280.29+3.57%+20.83%374.56M388.10M+3.61%+18.11%-0.5%
Q4 FY20100.250.34+36.00%+54.55%289.08M389.30M+34.67%+20.51%+12.7%
Q3 FY20100.230.24+4.35%+33.33%339.55M344.40M+1.43%+22.94%-7.0%
Q2 FY20100.230.24+4.35%+33.33%326.68M350.70M+7.35%+34.56%+0.3%
Q1 FY20100.190.24+26.32%+200.00%259.18M328.60M+26.79%+74.44%-7.1%
Q4 FY20090.190.22+15.79%+57.14%283.25M323.04M+14.05%+39.51%+11.8%
Q3 FY20090.160.18+12.50%+12.50%249.54M280.13M+12.26%+18.70%-5.7%
Q2 FY20090.140.18+28.57%+28.57%202.69M260.62M+28.58%+18.90%+26.8%
Q1 FY20090.110.08-27.27%-33.33%266.90M188.37M-29.42%+0.09%+10.5%
Q4 FY20080.140.140.00%0.00%231.50M231.55M+0.02%+22.22%-2.8%
Q3 FY20080.140.16+14.29%+33.33%206.50M235.99M+14.28%+50.41%-12.0%
Q2 FY20080.130.14+7.69%+55.56%198.81M219.19M+10.25%+56.29%+18.1%
Q1 FY20080.110.12+9.09%+71.43%167.85M188.19M+12.12%+64.75%-17.2%
Q4 FY20070.120.14+16.67%+100.00%161.68M189.45M+17.17%+68.30%+20.3%
Q3 FY20070.090.12+33.33%+140.00%121.04M156.90M+29.63%+63.73%+5.1%
Q2 FY20070.070.09+28.57%+80.00%118.63M140.25M+18.22%+61.16%+32.3%
Q1 FY20070.060.07+16.67%+75.00%97.89M114.23M+16.70%+47.85%+8.7%
Q4 FY20060.060.07+16.67%-53.33%91.15M112.57M+23.49%+56.14%+17.5%
Q3 FY20060.050.050.00%-16.67%89.41M95.83M+7.18%+57.43%-10.2%
Q2 FY20060.050.05+10.69%+25.00%75.40M87.03M+15.42%+64.96%-10.9%
Q1 FY20060.020.04+92.40%+33.33%61.46M77.26M+25.70%+85.65%+23.1%
Q4 FY20050.050.15+200.00%+275.00%26.22M72.09M+174.98%+59.52%-9.9%
Q3 FY20050.030.06+90.96%+200.00%45.20M60.87M+34.68%+71.51%+25.3%
Q2 FY20050.020.04+90.48%+100.00%41.97M52.76M+25.70%+69.87%+26.3%
Q1 FY20050.020.03+35.14%+979.14%31.20M41.61M+33.38%+53.79%-20.6%
Q4 FY20040.020.04+75.36%—41.95M45.19M+7.74%+63.78%+15.3%
Q3 FY20040.010.02+83.82%—17.75M35.49M+99.96%+51.72%+17.8%
Q2 FY20040.010.02+162.47%+289.11%12.44M31.06M+149.65%+44.77%-7.0%
Q1 FY2004—0.00———27.06M—+40.68%+7.1%
Q4 FY2003—-0.02———27.59M—+30.50%-1.5%
Q3 FY2003-0.01-0.01-14.36%—29.25M23.39M-20.02%+36.95%+0.6%
Q2 FY20030.000.01+350.88%—10.75M21.45M+99.56%+10.66%+4.3%
Q1 FY2003-0.01-0.01-47.02%—38.40M19.24M-49.91%+33.49%+1.5%
Q4 FY2002-0.01-0.02-38.22%—33.76M21.15M-37.37%+32.05%+1.5%
Q3 FY2002-0.03-0.04-28.58%—12.83M17.08M+33.19%+57.27%-9.8%
Q2 FY2002-0.02-0.02-25.94%—24.94M19.39M-22.27%+52.41%+0.6%
Q1 FY2002-0.03-0.03-10.46%—15.84M14.41M-9.03%+19.29%-2.2%
Q4 FY2001-0.02-0.02-16.28%—18.30M16.01M-12.50%+49.57%-5.6%
Q3 FY2001-0.03-0.03-13.34%—12.11M10.86M-10.32%+38.20%+1.0%
Q2 FY2001-0.03-0.03-2.85%—12.70M12.72M+0.16%+333.69%+0.6%
Q1 FY2001-0.02-0.02-18.91%—13.83M12.08M-12.65%—-10.4%
Q4 FY2000-0.02-0.02-5.76%—12.04M10.71M-11.11%—-2.6%
Q3 FY2000-0.02-0.03-25.00%—10.86M7.86M-27.65%—+10.5%
Q2 FY2000—-0.05———5.13M——-9.6%
Q2 FY2000-0.08-0.05+37.50%—6.91M2.93M-57.56%—-5.2%

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Q4 FY2026

What the market is waiting for

From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.

High importanceWaiting for 28 Jan

Da Vinci surgery growth

ExpectedWorldwide da Vinci procedure growth of about 13%company guidance
The resultComes with the report on 28 Jan

More procedures drive recurring sales of instruments and accessories used in surgery.

Beat record

On average, analysts' EPS estimate was 12.9% off the result, either way, and their revenue estimate 3.5%, over the last 12 quarters.

EPS beats
82 / 104
Revenue beats
84 / 104
Average EPS surprise, last 12
+12.9%
Since
July 2000

See also:Forecast,EPS,Income statement

Common questions about Intuitive Surgical's earnings

Source: Financial Modeling PrepVerified against SEC filings